The article discusses California-based Allez Health securing $60 million in Series A+ financing, led by strategic investor Osang Healthcare. Allez Health is a continuous glucose monitoring biosensor platform that analyzes health datasets across various afflictions to improve patient performance. The funding will be used for operations, regulatory approvals, manufacturing, and clinical trials. The company’s leadership team consists of former Dexcom leaders.
Highlights of the article:
1. Allez Health secures $60 million in Series A+ financing led by Osang Healthcare.
2. The company is focused on developing a continuous glucose monitoring biosensor platform.
3. The leadership team of Allez Health consists of former Dexcom leaders, bringing expertise to the company.
In summary, the article highlights Allez Health’s successful funding round and its focus on utilizing sensor technology for continuous glucose monitoring to enhance patient outcomes. The company’s leadership team’s experience in Dexcom adds credibility to their offerings.
Editorial content by Peyton Hawthorne
